Skip to main content
Top

Current Heart Failure Reports

Issue 5/2018

Content (5 Articles)

Biomarkers of Heart Failure (W Tang and J Grodin, Section Editors)

Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis

Nimesh Patel, Dharam J. Kumbhani

Open Access Comorbidities of Heart Failure (C Angermann, Section Editor)

Heart Failure and Stroke

Katja Schumacher, Jelena Kornej, Eduard Shantsila, Gregory Y. H. Lip

Open Access Comorbidities of Heart Failure (C Angermann, Section Editor)

Peripartum Cardiomyopathy: an Update

Feriel Azibani, Karen Sliwa

Comorbidities of Heart Failure (C. Angermann, Section Editor)

Cardiorenal Interactions Revisited: How to Improve Heart Failure Outcomes in Patients With Chronic Kidney Disease

Mattia Arrigo, Pietro E. Cippà, Alexandre Mebazaa

Devices (C. Veltmann, Section Editor)

Non-response to Cardiac Resynchronization Therapy

Syed Yaseen Naqvi, Anas Jawaid, Ilan Goldenberg, Valentina Kutyifa

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine